Colombia boasts one of the larger pharmaceutical markets in Latin America, though it continues to be overshadowed by still larger markets, including Mexico, Brazil and Argentina. While the government's continued commitment to health and pharmaceutical reform make the country appealing for investment, Colombia's continued battle against counterfeit medicines and troublesome intellectual property regime continue to keep it from becoming a regional outperformer.

Key View

SWOT

Industry Forecast

Industry Risk/Reward Index

Regulatory Development

Market Overview

Competitive Landscape

Company Profile

Colombia Demographic Outlook Pharmaceuticals & Healthcare Glossary 

Pharmaceuticals & Healthcare Methodology